mRNA technology: from cancer therapy to COVID vaccines
An article discusses mRNA technology, originally developed for cancer therapies and now known through COVID-19 vaccines. A review article published in The Lancet confirms the link between mRNA vaccines and rare cases of myocarditis, particularly in young men, with disease risk being higher.